Stock Analysts

Novartis Unveils Upbeat ACZ885 Data (NVS)

Novartis ( NVS ) recently presented positive data from a pivotal trial studying its drug ACZ885 for the treatment of systemic juvenile idiopathic arthritis (SJIA), the most severe form of arthritis in children. The late stage trial (n=84) for SJIA met all the primary and secondary endpoints. Around 83.7% of the patients, between the ages 2 and 19 years, dosed with ACZ885 experienced at least a 30% improvement in symptoms versus 9.8% of those on placebo […]

Stock Analysts

Earnings Preview: KB Home (DHI) (KBH) (LEN)

KB Home ( KBH ) announced that it would release its results for the third quarter of fiscal 2011 that ended on August 31, 2011 before the market opens on September 23, 2011. Los Angeles, California-based KB Home realized an adjusted net loss of 43 cents in the second quarter of fiscal 2011, much wider than the Zacks Consensus Estimate of a loss of 32 cents per share. In the upcoming quarter, the Zacks Consensus Estimate for KB Home is pegged at a loss of 17 cents per share, reflecting an annualized decline of 736%. […]

Stock Analysts

NeuroMetrix Ships DPN Test (MDT) (NUROD)

Nerve testing devices maker NeuroMetrix ( NUROD ) has commenced the commercial shipments of its NC-stat DPNCheck test. The company launched the test at the annual conference of the American Diabetes Association (“ADA”) in San Diego, California, in July 2011. […]